Document is current
Any future updates will be listed below
-
Authors
Fredolini, Claudia https://orcid.org/0000-0002-7674-2014
Dodig-Crnković, Tea
Bendes, Annika https://orcid.org/0000-0001-9329-2353
Dahl, Leo https://orcid.org/0000-0003-1492-3052
Dale, Matilda https://orcid.org/0000-0002-5788-7744
Albrecht, Vincent https://orcid.org/0009-0003-1985-7733
Mattsson, Cecilia
Thomas, Cecilia E. https://orcid.org/0000-0001-6201-6380
Torinsson Naluai, Åsa https://orcid.org/0000-0002-0504-6492
Gisslen, Magnus
Beck, Olof
Roxhed, Niclas https://orcid.org/0000-0002-7147-6730
Schwenk, Jochen M. https://orcid.org/0000-0001-8141-8449
-
Funding
Funding for this research was provided by:
VINNOVA (2020-04451)
Familjen Erling-Perssons Stiftelse (Future-proofing against COVID-19)
Knut och Alice Wallenbergs Stiftelse (Human Protein Atlas, WASP)
Science for Life Laboratory (2020.0182, 2020.0241, VC-2022-04451)
- License Information
-
More Information
Article History
Received: 12 October 2022
Accepted: 7 March 2024
First Online: 2 April 2024
Competing interests
: O.B. and N.R. are co-founders of Capitainer AB, a company that commercialized the blood collection device for microsampling. J.M.S. has, unrelated to the presented work, received speaker fees from Roche Diagnostics, travel support from Luminex Corp. and Olink AB, and conducted contract research for Luminex Corp. and Capitainer AB. All other authors declare no competing interests.
